WESTMINSTER, Colo., June 24, 2019 /PRNewswire/ –Cerapedics, a privately-held orthobiologics company, today announced the appointment of Patrick O’Connor as Vice President of Clinical and Market Development. “We are pleased to welcome Mr. O’Connor to the Cerapedics team as we continue to enroll patients in our investigational device exemption (IDE) clinical trial evaluating the safety and efficacy of the next-generation …